| |
|
|
Session 43
Poster Presentations Mapping CTL Epitopes in Different Populations Wednesday 1:30 - 3:30 pm Hall D |
| 321 | HIV-1 Regulatory Protein (nef, tat, rev, vif, vpu, vpr)-CTL Responses and Epitope Mapping in Subtype A/E-Infected Thais with CD4 >300 cells/mm3 S. Buranapraditkun*1, K. Ruxrungtham1, S. Sirivichayakul1, S. Kosonsiriluk1, S. Kerdsanti1, P. Hansasuta1, S. Rowland-Jones2, P. Phanuphak1 1Bangkok, Thailand and 2Oxford, UK |
| 322 | A Novel HLA-Cw1-restricted gag A/E CTL Epitope, YSPVSILDI, Identified in HIV-1 Infected Thai Patients K Ruxrungtham*1, S Buranapraditkun1, P Hansasuta1, S Rowland-Jones2, S Sirivichayakul1, M Honda3, P Warachit1, P Phanuphak1 1Bangkok, Thailand; 2Oxford, UK; and 3Tokyo, Japan |
| 323 | Differences in the Expressed HLA Class I Alleles Determine the Differential Clustering of HIV-1-Specific T-cell Responses in Infected Chinese and Caucasians X. G. Yu*1, B. Perkins1, M. M. Addo1, F. Wei2, A. Rathod1, M. Parta3, P. Lee1, C. Adams1, A. Wurcel1, N. Frahm1, E. S. Rosenberg1, C. Brander1, Y. Cao2, B. D. Walker1, M. Altfeld1 1Partners AIDS Res Ctr, Mass Gen Hosp /Div of AIDS, Harvard Med Sch, Boston, MA; 2Chinese Academy of Preventive Med, Beijing, China; and 3Belvue Hosp, New York, NY |
| 324 | Cross-reactive HIV-1 Clade B CD8+ T-lymphocytes in Patients Infected with HIV-1 Subtype A/G (CRF02) Living in Ivory Coast (West Africa) A. Inwoley*1, P. Recordon2, A. Minga3, J. Gaston4, M. Dupuis4, B. Masquelier2, H. Fleury2, F. Rouet1, J. G. Guillet4, M. Andrieu4, ANRS 1220 PRIMOCI group3 1CeDReS/PAC-CI, Abidjan, Côte d'Ivoire; 2Lab de Virologie, Univ de Bordeaux, France; 3PRIMO-CI/PAC-CI, Abidjan, Côte d'Ivoire; and 4Inst Cochin, Paris, France |
| 325 | Nef-specific CD8+ T-cells in HIV-1 Subtype C Infected Individuals Target a Highly Conserved Epitope-rich Central Region Restricted by Novel and Unpredicted HLA Class I Alleles Common in Southern Africa T. Mashishi*1, S. Nyoka1, P. Mohube1, G. Khoury1, M. Paximadis1, A. Puren1, R. Donovan2, C. Williamson3, H. Sheppard2, C. Gray1 1Natl Inst for Communicable Diseases, Johannesburg, South Africa; 2HIV Vaccine Trials Network Central Lab, Richmond, CA; and 3Univ of Cape Town, South Africa |
| 326 | Tools for Searching Optimal CTL Epitopes in Reactive Regions K. Yusim*1, C. Calef1, K. Kommander1, J. J. Szinger1, B. T. Korber1,2 1Los Alamos Natl Lab, NM and 2Santa Fe Inst, NM |
| 327 | HIV Adaptation to HLA-restricted Immune Responses-Implications for Vaccine Design and Evaluation S. A. Mallal*, C. B. Moore, F. Carvalho, A. Patterson, C. Liu, D. Goodridge, D. Sayer, I. James, M. John Ctr Clin Immunology and BioMed Statistics, Perth, Australia |
| 328 | Sequence Analysis and Identification of CTL Escape Yi Liu*1, David C. Nickle1, Jianhong Cao2, Hong Zhao1, Indira Genowati1, John McNevin2, Katie Davis1, Lisa Rose1, M. Juliana McElrath2, James I. Mullins11 1Univ of Washington, Seattle and 2Fred Hutchinson Cancer Res Ctr, Seattle, WA |
| 329 | Frequency of CD8 T-cell Responses to Novel HIV-1 Specific Epitopes Among Individuals of Different Racial Backgrounds S. Sabbaj1, A. Bansal1, D. Ritter1, C. Perkins1, B. Edwards1, E. Gough1, J. Tang1, B. Korber2, C. Wilson1, R. Kaslow1, M. Mulligan1, P. Goepfert1 1Univ of Alabama at Birmingham and 2Los Alamos Natl Lab, NM |